Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Malaria Treatment Options in Pregnancy in Tanzania
NCT00146731Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Jan 2004
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of amodiaquine, artesunate and chlorproguanil + dapsone in Malaria (4 arms), sponsored by London School of Hygiene & Tropical Medicine. Primary endpoint: Treatment failure at Day 32. Started Jan 2004; status: completed.
02
Drugs
amodiaquineartesunatechlorproguanil + dapsone
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT00146731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00146731.